Treatment of COPD groups GOLD A and B with inhaled corticosteroids in the COSYCONET cohort: determinants and consequences
GOLD A and B COPD patients are often treated with inhaled corticosteroids (ICS), which may benefit only a subgroup of these patients. Click to read more.
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
14 April 2021
|
| In: |
The International journal of chronic obstructive pulmonary disease
Year: 2021, Volume: 16, Pages: 987-998 |
| ISSN: | 1178-2005 |
| DOI: | 10.2147/COPD.S304532 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2147/COPD.S304532 Verlag, lizenzpflichtig, Volltext: https://www.dovepress.com/treatment-of-copd-groups-gold-a-and-b-with-inhaled-corticosteroids-in--peer-reviewed-fulltext-article-COPD |
| Author Notes: | Johanna I. Lutter, Rudolf A. Jörres, Franziska C. Trudzinski, Peter Alter, Christina Kellerer, Henrik Watz, Tobias Welte, Robert Bals, Diego Kauffmann-Guerrero, Jürgen Behr, Rolf Holle, Claus F. Vogelmeier, Kathrin Kahnert, on behalf of the COSYCONET study group |
| Summary: | GOLD A and B COPD patients are often treated with inhaled corticosteroids (ICS), which may benefit only a subgroup of these patients. Click to read more. |
|---|---|
| Item Description: | Gesehen am 18.05.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1178-2005 |
| DOI: | 10.2147/COPD.S304532 |